发明名称 PHENANTHROLINE DERIVATIVES
摘要 The present invention provides a phenanthroline derivative of formula (I) wherein, for example, R1 is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-(2-4C)alkoxycarbonyl or N-[amino-(2-8C)alkyl]carbamoyl; R2 is, for example, hydrogen, carboxy, (1-6C)alkoxycarbonyl, carbamoyl, N-(1-8C)alkylcarbamoyl, N,N-di-(1-8C)alkylcarbamoyl, N-{1-4C)alkylcyclohexylcarbamoyl, 1,2,3,4,-tetrahydro-isoquinolin-2-ylcarbonyl or N,N-[di-(1-4C)alkyl]thiocarbamoyl; R3 and R4, which may be the same or different, are, for example, hydrogen or halo; and R5 is, for example, hydrogen, di-(1-4C)alkylamino or halo; or a pharmaceutically-acceptable salt thereof. The invention further provides pharmaceutical compositions comprising phenanthroline derivatives, processes for making the same and their use in producing an anti-fibroproliferative effect.
申请公布号 CA2308551(C) 申请公布日期 2010.02.16
申请号 CA19982308551 申请日期 1998.10.26
申请人 FIBROGEN, INC.;ZENECA LIMITED 发明人 EDWARDS, PHILIP NEIL;LARGE, MICHAEL STEWART;HALES, NEIL JAMES;MARTIN, GEORGE R.;HUANG, XINFAN
分类号 C07D471/04;A61K31/47;A61K31/4745;A61K31/496;A61K31/5377;A61P1/16;A61P17/02;A61P19/02;A61P29/00;A61P43/00;C07D221/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址